Home › Companies › Monopar Therapeutics Inc. › 2025-2026
At Monopar Therapeutics Inc.'s shareholder meeting held June 22, 2026, in the 2025-2026 proxy season, 95 asset managers reported how they voted on 9 ballot items in their SEC Form N-PX filings, covering 946 separate fund positions. On the most widely held item on that ballot — TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS ON AN ADVISORY, NON-BINDING BASIS. — Monopar Therapeutics Inc.'s filing reports the proposal as approved, with 88% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Monopar Therapeutics Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 23, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Monopar Therapeutics Inc.’s Form 8-K, filed June 23, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 22, 2026: 9 items on Monopar Therapeutics Inc.’s Form 8-K, filed June 23, 2026: 6 elected · 3 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Monopar Therapeutics Inc. in the interactive database Compare manager voting policies
These tallies are Monopar Therapeutics Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 23, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Christopher M. Starr, Ph.D. | 4,203,485 | -- | -- | 757,652 | 799,255 | 85% | Elected | — |
| Elect Director: Chandler D. Robinson, MD MBA MSc | 4,447,108 | -- | -- | 514,029 | 799,255 | 90% | Elected | — |
| Elect Director: Raymond W. Anderson, MBA MS | 4,671,362 | -- | -- | 289,775 | 799,255 | 94% | Elected | — |
| Elect Director: Kim R. Tsuchimoto | 4,325,379 | -- | -- | 635,758 | 799,255 | 87% | Elected | — |
| Elect Director: Lavina Talukdar, CFA | 4,897,733 | -- | -- | 63,404 | 799,255 | 99% | Elected | — |
| Elect Director: Nicole Sweeny | 4,911,758 | -- | -- | 49,379 | 799,255 | 99.0% | Elected | — |
| 2. Approval of the Compensation of the Company ' s Named Executive Officers on an Advisory, Non-Binding Basis The voting results with respect to the proposal to approve the compensation of the Company's NEOs on an advisory, non-binding basis | 4,355,628 | 604,858 | 651 | -- | 799,255 | 88% | Approved | — |
| 3. Approval of the Company ' s 2026 Stock Incentive Plan The voting results with respect to the proposal to approve the Company's 2026 Stock Incentive Plan | 4,444,209 | 516,570 | 358 | -- | 799,255 | 90% | Approved | — |
| 4. Ratification of the Company ' s Selection of Independent Registered Public Accounting Firm The voting results with respect to the proposal to ratify the selection of BPM LLP to serve as the Company's independent registered public accounting firm for the yea | 5,759,198 | 998 | 196 | -- | -- | 99.9% | Approved | — |
Source: Monopar Therapeutics Inc., Form 8-K, filed with the SEC on June 23, 2026 — read the filing on EDGAR.
Each item below shows how the 95 asset managers that disclosed a Monopar Therapeutics Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Chandler D. Robinson
Monopar Therapeutics Inc.’s own tally for this item (“Elect Director: Chandler D. Robinson, MD MBA MSc”): 4,447,108 for, 514,029 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “2 Proposal 1 - Election of Directors At the Annual Meeting, the voting results with respect to the proposal for the election of directors, included in the Company's Proxy Statement on Schedule 14A for the Annual Meeting, were as follows: Accordingly, each of the foregoing persons was elected as a d…”
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 314,447 for, 9,291 withheld, 1,111 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 156,846 | 0 | 0 | 195 | For |
| BlackRock | 65,021 | 0 | 0 | 0 | For |
| BNY Mellon | 27,723 | 0 | 0 | 0 | For |
| Neuberger Berman | 25,313 | 0 | 0 | 0 | For |
| Charles Schwab | 12,558 | 0 | 0 | 0 | For |
| Russell Investments | 6,173 | 0 | 0 | 0 | For |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 3,350 | Withhold |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 2,337 | 0 | 0 | 0 | For |
| Global X | 1,948 | 0 | 0 | 0 | For |
| Pacific Life | 1,536 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 1,532 | Withhold |
| AQR | 0 | 0 | 0 | 1,443 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 1,243 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 1,111 | 0 | Abstain |
| Bridge Builder Trust | 859 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 647 | Withhold |
| SEI | 600 | 0 | 0 | 0 | For |
| Nationwide | 526 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 519 | Withhold |
| Voya | 0 | 0 | 0 | 504 | Withhold |
| Venerable Variable Insurance Trust | 337 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 330 | Withhold |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Christopher M. Starr
Monopar Therapeutics Inc.’s own tally for this item (“Elect Director: Christopher M. Starr, Ph.D.”): 4,203,485 for, 757,652 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “2 Proposal 1 - Election of Directors At the Annual Meeting, the voting results with respect to the proposal for the election of directors, included in the Company's Proxy Statement on Schedule 14A for the Annual Meeting, were as follows: Accordingly, each of the foregoing persons was elected as a d…”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 196,929 for, 59,684 withheld, 68,235 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 156,749 | 0 | 1 | 290 | For |
| BlackRock | 0 | 0 | 65,021 | 0 | Abstain |
| BNY Mellon | 27,723 | 0 | 0 | 0 | For |
| Neuberger Berman | 0 | 0 | 0 | 25,313 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 12,558 | Withhold |
| Russell Investments | 0 | 0 | 0 | 6,173 | Withhold |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 3,350 | Withhold |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 1,030 | 0 | 0 | 1,307 | Mixed |
| Global X | 0 | 0 | 0 | 1,948 | Withhold |
| Pacific Life | 0 | 0 | 0 | 1,536 | Withhold |
| Brighthouse | 0 | 0 | 0 | 1,532 | Withhold |
| AQR | 0 | 0 | 0 | 1,443 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 1,243 | 0 | Abstain |
| John Hancock | 0 | 0 | 1,111 | 0 | Abstain |
| Bridge Builder Trust | 0 | 0 | 859 | 0 | Abstain |
| ProShares | 0 | 0 | 0 | 647 | Withhold |
| SEI | 0 | 0 | 0 | 600 | Withhold |
| Nationwide | 0 | 0 | 0 | 526 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 519 | Withhold |
| Voya | 0 | 0 | 0 | 504 | Withhold |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 337 | Withhold |
| American Century | 0 | 0 | 0 | 330 | Withhold |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kim R. Tsuchimoto
Monopar Therapeutics Inc.’s own tally for this item (“Elect Director: Kim R. Tsuchimoto”): 4,325,379 for, 635,758 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “2 Proposal 1 - Election of Directors At the Annual Meeting, the voting results with respect to the proposal for the election of directors, included in the Company's Proxy Statement on Schedule 14A for the Annual Meeting, were as follows: Accordingly, each of the foregoing persons was elected as a d…”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 267,443 for, 56,294 withheld, 1,112 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 156,944 | 0 | 1 | 96 | For |
| BlackRock | 65,021 | 0 | 0 | 0 | For |
| BNY Mellon | 27,723 | 0 | 0 | 0 | For |
| Neuberger Berman | 0 | 0 | 0 | 25,313 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 12,558 | Withhold |
| Russell Investments | 0 | 0 | 0 | 6,173 | Withhold |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 3,350 | Withhold |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 2,337 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 1,948 | Withhold |
| Pacific Life | 1,536 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 1,532 | Withhold |
| AQR | 0 | 0 | 0 | 1,443 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 1,243 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 1,111 | 0 | Abstain |
| Bridge Builder Trust | 859 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 647 | Withhold |
| SEI | 0 | 0 | 0 | 600 | Withhold |
| Nationwide | 326 | 0 | 0 | 200 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 519 | Withhold |
| Voya | 0 | 0 | 0 | 504 | Withhold |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 337 | Withhold |
| American Century | 0 | 0 | 0 | 330 | Withhold |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lavina Talukdar
Monopar Therapeutics Inc.’s own tally for this item (“Elect Director: Lavina Talukdar, CFA”): 4,897,733 for, 63,404 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “2 Proposal 1 - Election of Directors At the Annual Meeting, the voting results with respect to the proposal for the election of directors, included in the Company's Proxy Statement on Schedule 14A for the Annual Meeting, were as follows: Accordingly, each of the foregoing persons was elected as a d…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 324,493 for, 356 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 157,041 | 0 | 0 | 0 | For |
| BlackRock | 65,021 | 0 | 0 | 0 | For |
| BNY Mellon | 27,723 | 0 | 0 | 0 | For |
| Neuberger Berman | 25,313 | 0 | 0 | 0 | For |
| Charles Schwab | 12,558 | 0 | 0 | 0 | For |
| Russell Investments | 6,173 | 0 | 0 | 0 | For |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 3,350 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 2,337 | 0 | 0 | 0 | For |
| Global X | 1,948 | 0 | 0 | 0 | For |
| Pacific Life | 1,536 | 0 | 0 | 0 | For |
| Brighthouse | 1,532 | 0 | 0 | 0 | For |
| AQR | 1,443 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 1,243 | 0 | 0 | 0 | For |
| John Hancock | 1,111 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 859 | 0 | 0 | 0 | For |
| ProShares | 647 | 0 | 0 | 0 | For |
| SEI | 600 | 0 | 0 | 0 | For |
| Nationwide | 526 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 519 | 0 | 0 | 0 | For |
| Voya | 504 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 337 | 0 | 0 | 0 | For |
| American Century | 330 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Nicole Sweeny
Monopar Therapeutics Inc.’s own tally for this item (“Elect Director: Nicole Sweeny”): 4,911,758 for, 49,379 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “2 Proposal 1 - Election of Directors At the Annual Meeting, the voting results with respect to the proposal for the election of directors, included in the Company's Proxy Statement on Schedule 14A for the Annual Meeting, were as follows: Accordingly, each of the foregoing persons was elected as a d…”
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 324,549 for, 300 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 157,041 | 0 | 0 | 0 | For |
| BlackRock | 65,021 | 0 | 0 | 0 | For |
| BNY Mellon | 27,723 | 0 | 0 | 0 | For |
| Neuberger Berman | 25,313 | 0 | 0 | 0 | For |
| Charles Schwab | 12,558 | 0 | 0 | 0 | For |
| Russell Investments | 6,173 | 0 | 0 | 0 | For |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 3,350 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 2,337 | 0 | 0 | 0 | For |
| Global X | 1,948 | 0 | 0 | 0 | For |
| Pacific Life | 1,536 | 0 | 0 | 0 | For |
| Brighthouse | 1,532 | 0 | 0 | 0 | For |
| AQR | 1,443 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 1,243 | 0 | 0 | 0 | For |
| John Hancock | 1,111 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 859 | 0 | 0 | 0 | For |
| ProShares | 647 | 0 | 0 | 0 | For |
| SEI | 600 | 0 | 0 | 0 | For |
| Nationwide | 526 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 519 | 0 | 0 | 0 | For |
| Voya | 504 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 337 | 0 | 0 | 0 | For |
| American Century | 330 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Raymond W. Anderson
Monopar Therapeutics Inc.’s own tally for this item (“Elect Director: Raymond W. Anderson, MBA MS”): 4,671,362 for, 289,775 withheld, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “2 Proposal 1 - Election of Directors At the Annual Meeting, the voting results with respect to the proposal for the election of directors, included in the Company's Proxy Statement on Schedule 14A for the Annual Meeting, were as follows: Accordingly, each of the foregoing persons was elected as a d…”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 219,312 for, 38,413 withheld, 67,123 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 156,750 | 0 | 0 | 290 | For |
| BlackRock | 0 | 0 | 65,021 | 0 | Abstain |
| BNY Mellon | 27,723 | 0 | 0 | 0 | For |
| Neuberger Berman | 0 | 0 | 0 | 25,313 | Withhold |
| Charles Schwab | 12,558 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 0 | 0 | 6,173 | Withhold |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 3,350 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 1,030 | 0 | 0 | 1,307 | Mixed |
| Global X | 0 | 0 | 0 | 1,948 | Withhold |
| Pacific Life | 0 | 0 | 0 | 1,536 | Withhold |
| Brighthouse | 1,532 | 0 | 0 | 0 | For |
| AQR | 1,443 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 1,243 | 0 | Abstain |
| John Hancock | 1,111 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 859 | 0 | Abstain |
| ProShares | 647 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 600 | Withhold |
| Nationwide | 0 | 0 | 0 | 526 | Withhold |
| AIG/SunAmerica | 519 | 0 | 0 | 0 | For |
| Voya | 504 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 337 | Withhold |
| American Century | 330 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
90% Approved · of votes cast
Description as filed by funds: TO APPROVE THE 2026 STOCK INCENTIVE PLAN.
Monopar Therapeutics Inc.’s own tally for this item (“3. Approval of the Company ' s 2026 Stock Incentive Plan The voting results with respect to the proposal to approve the Company's 2026 Stock Incentive Plan”): 4,444,209 for, 516,570 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Accordingly, the Company's stockholders approved the Company's 2026 Stock Incentive Plan.”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 156,846 | 195 | 0 | 0 | For |
| BlackRock | 65,021 | 0 | 0 | 0 | For |
| BNY Mellon | 27,723 | 0 | 0 | 0 | For |
| Neuberger Berman | 25,313 | 0 | 0 | 0 | For |
| Charles Schwab | 12,558 | 0 | 0 | 0 | For |
| Russell Investments | 6,173 | 0 | 0 | 0 | For |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 3,350 | 0 | 0 | Against |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 2,337 | 0 | 0 | 0 | For |
| Global X | 1,948 | 0 | 0 | 0 | For |
| Meeder Funds | 1,723 | 0 | 0 | 0 | For |
| Pacific Life | 1,536 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 1,532 | 0 | 0 | Against |
| AQR | 0 | 1,443 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 1,243 | 0 | 0 | 0 | For |
| John Hancock | 0 | 1,111 | 0 | 0 | Against |
| Bridge Builder Trust | 859 | 0 | 0 | 0 | For |
| ProShares | 0 | 647 | 0 | 0 | Against |
| SEI | 600 | 0 | 0 | 0 | For |
| Nationwide | 526 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 519 | 0 | 0 | Against |
| Voya | 0 | 504 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 337 | 0 | 0 | 0 | For |
Fund voting reports, all 38 managers: 316,464 for, 10,108 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Saturn V Capital Management LP | 186,821 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 186,821 for.
Combines 2 wordings of this item as funds reported it.
88% Approved · of votes cast
Description as filed by funds: TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS ON AN ADVISORY, NON-BINDING BASIS.
Monopar Therapeutics Inc.’s own tally for this item (“2. Approval of the Compensation of the Company ' s Named Executive Officers on an Advisory, Non-Binding Basis The voting results with respect to the proposal to approve the compensation of the Company's NEOs on an adviso”): 4,355,628 for, 604,858 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Accordingly, the Company's stockholders approved the compensation of the Company's NEOs on an advisory, non-binding basis.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 157,040 | 1 | 0 | 0 | For |
| BlackRock | 65,021 | 0 | 0 | 0 | For |
| BNY Mellon | 0 | 27,723 | 0 | 0 | Against |
| Neuberger Berman | 25,313 | 0 | 0 | 0 | For |
| Charles Schwab | 12,558 | 0 | 0 | 0 | For |
| Russell Investments | 6,173 | 0 | 0 | 0 | For |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 3,350 | 0 | 0 | Against |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 1,307 | 1,030 | 0 | 0 | Mixed |
| Global X | 1,948 | 0 | 0 | 0 | For |
| Meeder Funds | 1,723 | 0 | 0 | 0 | For |
| Pacific Life | 1,536 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 1,532 | 0 | 0 | Against |
| AQR | 0 | 1,443 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 1,243 | 0 | 0 | 0 | For |
| John Hancock | 0 | 1,111 | 0 | 0 | Against |
| Bridge Builder Trust | 859 | 0 | 0 | 0 | For |
| ProShares | 0 | 647 | 0 | 0 | Against |
| SEI | 600 | 0 | 0 | 0 | For |
| Nationwide | 526 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 519 | 0 | 0 | Against |
| Voya | 504 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 337 | 0 | 0 | 0 | For |
Fund voting reports, all 38 managers: 288,492 for, 38,080 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 2,372,522 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 665,055 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 0 | 428,474 | 0 | 0 | Against |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 323,745 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 223,190 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 186,821 | 0 | 0 | 0 | For |
| Wellington | 135,740 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 0 | 120,714 | 0 | 0 | Against |
| Vivo Capital, LLC | 90,500 | 0 | 0 | 0 | For |
| BlackRock | 54,767 | 6,869 | 0 | 0 | Mixed |
| Newton Investment Management North America, LLC | 0 | 52,362 | 0 | 0 | Against |
| Neuberger Berman | 48,472 | 0 | 0 | 0 | For |
| State Street | 40,233 | 186 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 37,911 | 0 | 0 | Against |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0 | 33,156 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 30,472 | 0 | 0 | Against |
| BALYASNY ASSET MANAGEMENT L.P. | 29,659 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 25,998 | 0 | 0 | Against |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 21,412 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 13,964 | 0 | 0 | Against |
| Charles Schwab | 12,558 | 0 | 0 | 0 | For |
| Russell Investments | 12,107 | 0 | 0 | 0 | For |
| Citadel | 5,209 | 0 | 0 | 0 | For |
| Vanguard | 5,040 | 9 | 0 | 0 | For |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 0 | 4,912 | 0 | 0 | Against |
No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE SELECTION OF BPM LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026.
Monopar Therapeutics Inc.’s own tally for this item (“4. Ratification of the Company ' s Selection of Independent Registered Public Accounting Firm The voting results with respect to the proposal to ratify the selection of BPM LLP to serve as the Company's independent regis”): 5,759,198 for, 998 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Accordingly, the Company's stockholders ratified the selection of BPM LLP to serve as the Company's independent registered public accounting firm for the year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 326,572 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 157,041 | 0 | 0 | 0 | For |
| BlackRock | 65,021 | 0 | 0 | 0 | For |
| BNY Mellon | 27,723 | 0 | 0 | 0 | For |
| Neuberger Berman | 25,313 | 0 | 0 | 0 | For |
| Charles Schwab | 12,558 | 0 | 0 | 0 | For |
| Russell Investments | 6,173 | 0 | 0 | 0 | For |
| Goldman Sachs | 5,663 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 3,350 | 0 | 0 | 0 | For |
| Lincoln Financial | 3,000 | 0 | 0 | 0 | For |
| Fidelity | 2,340 | 0 | 0 | 0 | For |
| Equitable | 2,337 | 0 | 0 | 0 | For |
| Global X | 1,948 | 0 | 0 | 0 | For |
| Meeder Funds | 1,723 | 0 | 0 | 0 | For |
| Pacific Life | 1,536 | 0 | 0 | 0 | For |
| Brighthouse | 1,532 | 0 | 0 | 0 | For |
| AQR | 1,443 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 1,243 | 0 | 0 | 0 | For |
| John Hancock | 1,111 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 859 | 0 | 0 | 0 | For |
| ProShares | 647 | 0 | 0 | 0 | For |
| SEI | 600 | 0 | 0 | 0 | For |
| Nationwide | 526 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 519 | 0 | 0 | 0 | For |
| Voya | 504 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 337 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. All 38 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 6,699,062 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.34% |
| 2 | BlackRock | 0.97% |
| 3 | BNY Mellon | 0.41% |
| 4 | Neuberger Berman | 0.38% |
| 5 | Charles Schwab | 0.19% |
| 6 | Russell Investments | 0.09% |
| 7 | Goldman Sachs | 0.08% |
| 8 | ETFis Series Trust I | 0.05% |
| 9 | Lincoln Financial | 0.04% |
| 10 | Fidelity | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 35.42% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 9.93% |
| 3 | Polar Capital Holdings Plc | 6.40% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 4.83% |
| 5 | Siren, L.L.C. | 3.33% |
| 6 | Saturn V Capital Management LP | 2.79% |
| 7 | Wellington | 2.03% |
| 8 | ADAR1 Capital Management, LLC | 1.80% |
| 9 | Vivo Capital, LLC | 1.35% |
| 10 | BlackRock | 0.92% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Janus Henderson Group plc | 17.50% | DEF14A |
| RA Capital Management, L.P. | 9.97% | 13G |
| Diane Hendricks | 9.87% | DEF14A |
| AstraZeneca PLC | 7.80% | 13G |
| Adage Capital Management, L.P. | 4.84% | 13G |
| Chandler D. Robinson, Chief Executive Officer and Director | 4.82% | DEF14A |
| BlackRock | 4.73% | 13F |
| Saturn V Capital Management LP | 4.68% | 13G |
| Robinson Chandler | 4.59% | 13D |
| Vanguard Group | 4.39% | 13F |
Percentages above are of 6,699,062 shares outstanding, as reported by Monopar Therapeutics Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Monopar Therapeutics Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Monopar Therapeutics Inc. proxy season coverage: 2025-2026 (this page).
proxyvotesnow.com, “Monopar Therapeutics (MNPR) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/monopar-therapeutics-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.